HLYK

HealthLynked Corp. [HLYK] Stock Forecast

Buy or Sell ? Support and Resistance

What is MACD and how to read it?

How RSI can help?
RSI : 000

HLYK Stock Summary

In the News

09:08 29 Mar 2024 HLYK

HealthLynked revamps app to emphasize smooth communication between patients and healthcare providers

HealthLynked (OTCQB:HLYK) Corp said it is rolling out major updates to its HealthLynked (OTCQB:HLYK) app. The updates are each meant to streamline communication between users and their healthcare providers, according to a statement, while also ensuring the utmost security.

09:02 29 Mar 2024 HLYK

HealthLynked taps Bill Crupi as regional manager of healthcare services as it eyes growth

HealthLynked (OTCQB:HLYK) Corp named Bill Crupi, who has a track record of successfully managing medical facilities and maintaining compliance standards, as the regional manager of healthcare services, as the company eyes rapid growth. The Naples, Florida-based healthcare network company noted that Crupi brings with him “a wealth of experience” in operations management, human resources operations, IT management, accounting, and financial planning.

09:21 29 Mar 2024 HLYK

HealthLynked swings to a profit in 1Q; sees revenue grow

HealthLynked (OTCQB:HLYK), a provider of healthcare technologies, swung to a profit in the first quarter of 2023 following the divestment of ACO Health Partners in January. For the three months ended March 31, the company posted a profit of $1.45 million which the company noted was “a significant turnaround” from a loss of $1.17 million in the year-ago quarter.

09:34 29 Mar 2024 HLYK

HealthLynked strikes deal to sell ACO Health Partners for up to $3M in cash and $7M in IPO shares of PBACO

HealthLynked (OTCQB:HLYK) Corp revealed that it has signed a definitive agreement to sell its ACO Health Partners (AHP) subsidiary to PBACO Holding LLC (PBA), which does business as Palm Beach Accountable Care Organization (PBACO) in a cash-and-stock deal.  In a statement, HealthLynked (OTCQB:HLYK) founder CEO Dr Michael Dent said: "We are thrilled to be working with such a like-minded group that prioritizes physician efficiency and high-quality patient care.

09:06 29 Mar 2024 HLYK

HealthLynked Corp launches concierge membership program

HealthLynked (OTCQB:HLYK) Corp said its Naples Center for Functional Medicine has implemented a Concierge medical membership program for patients to provide better access, more time with physicians, and connectivity to HealthLynked (OTCQB:HLYK)'s online patient concierge services. With strong initial adoption from patients, the program is estimated to generate over $1 million in incremental annual revenue, the global healthcare network company said.

09:18 29 Mar 2024 HLYK

HealthLynked reports annual revenue growth of 50% to $9.2M

HealthLynked (OTCQB:HLYK) Corp has announced a strong rise in full-year 2021 revenue, supported by growth at its ACO and Management Service Organizations (MSO) divisions.  The company reported revenue of $9.2 million for the year to December 31, 2021, up 50% from the prior year.

11:18 29 Mar 2024 HLYK

HealthLynked announces updated version of Oohvie, its App for women's health

HealthLynked (OTCQB:HLYK) Corp has announced an updated version of Oohvie, its App for women's health that tracks menstrual cycles and other changes associated with ovulation. Oohvie was released in November 2020 and currently has over 30,000 downloads.

12:26 29 Mar 2024 HLYK

US indices mixed after weekly labour market report

12:05pm: Wall Street mixed  US stocks were mixed at the midday point as investors mulled fresh data on the labour market and inflation. At noon, the Dow Jones Industrial Average continued to climb, gaining 188 points, or 0.5% at 36,472 points, while the broader S&P 500 and tech-laden stock index Nasdaq Composite both dropped by 0.1% and 0.7%, respectively.

12:08 29 Mar 2024 HLYK

US indices mix after weekly labour market report

12:05pm: Wall Street mixed  US stocks were mixed at the midday point as investors turned to fresh data on the labour market and inflation report on Wednesday. At noon, the Dow Jones Industrial Average continued to climb, gaining 188 points, or 0.5% at 36,472 points, while the broader S&P 500 and tech-laden stock index Nasdaq Composite both dropped by 0.1% and 0.7%, respectively.

11:38 29 Mar 2024 HLYK

HealthLynked sees its 3Q revenue climb 98% to $4M on strong patient volume

HealthLynked (OTCQB:HLYK) Corp has announced third-quarter 2021 revenue of $4.0 million, a 98% year-over-year increase, as patient appointments rose 24%. The company also said its Health Services division's foundational patient services revenue increased 32% in 3Q, compared to a 10% decrease during the same period last year.

HLYK Financial details

Company Rating
Neutral
Market Cap
15.78M
Income
-4M
Revenue
5.95M
Book val./share
0.01
Cash/share
0
Dividend
-
Dividend %
-
Employees
53
Optionable
No
Shortable
Yes
Earnings
01 Apr 2024
P/E
-5.48
Forward P/E
-
PEG
0.85
P/S
3.71
P/B
14.03
P/C
-
P/FCF
-6.17
Quick Ratio
0.59
Current Ratio
0.66
Debt / Equity
1.35
LT Debt / Equity
0.47
-
-
EPS (TTM)
-0.02
EPS next Y
-
EPS next Q
1.58
EPS this Y
-23.14%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-13.21%
Revenue last 5Y
21%
Revenue Q/Q
-21.78%
EPS Q/Q
-82.05%
-
-
-
-
SMA20
20%
SMA50
-25%
SMA100
20%
Inst Own
0.03%
Inst Trans
0.99%
ROA
-70%
ROE
-285%
ROC
-1.67%
Gross Margin
81%
Oper. Margin
-65%
Profit Margin
-67%
Payout
-
Shs Outstand
267.43M
Shs Float
161.68M
-
-
-
-
Target Price
-
52W Range
0.033-0.109
52W High
-
52W Low
-
RSI
50.63
Rel Volume
0.96
Avg Volume
130.43K
Volume
125.31K
Perf Week
-3.56%
Perf Month
-9.54%
Perf Quarter
3.64%
Perf Half Y
20.04%
-
-
-
-
Beta
1.35
-
-
Volatility
0%, 0%
Prev Close
-0.61%
Price
0.0569
Change
-4.85%

HLYK Financial Performance

Yearly Fundamentals Overview

Last date of statement is 2022-12-31

Metric History 2018-12-312019-12-312020-12-312021-12-31 2022-12-31
2.02K2.02K2.02K2.02K2.02K
Revenue per share
0.030.040.040.040.02
Net income per share
-0.07-0.14-0.04-0.05-0.04
Operating cash flow per share
-0.03-0.02-0.01-0.02-0.02
Free cash flow per share
-0.03-0.02-0.01-0.02-0.02
Cash per share
0000.010
Book value per share
-0.04-0.030.010.030
Tangible book value per share
-0.04-0.04-0.040.010
Share holders equity per share
-0.04-0.030.010.030
Interest debt per share
0.030.040.0300.01
Market cap
10.64M13.87M16.1M104.35M16.67M
Enterprise value
12.24M16.33M18.83M102.04M17.9M
P/E ratio
-1.84-0.97-2.62-10.02-1.89
Price to sales ratio
4.713.452.6211.342.85
POCF ratio
-4.52-5.87-7.6-27.68-3.82
PFCF ratio
-4.51-5.84-7.51-27.54-3.8
P/B Ratio
-3.63-4.8811.9214.4953.03
PTB ratio
-3.63-4.8811.9214.4953.03
EV to sales
5.424.063.0711.093.05
Enterprise value over EBITDA
-2.844.06-5.87-24.09-3.45
EV to operating cash flow
-5.2-6.91-8.89-27.07-4.1
EV to free cash flow
-5.19-6.88-8.79-26.93-4.08
Earnings yield
-0.54-1.03-0.38-0.1-0.53
Free cash flow yield
-0.22-0.17-0.13-0.04-0.26
Debt to equity
-0.59-0.92.140.144.08
Debt to assets
4.071.010.360.090.28
Net debt to EBITDA
-0.370.61-0.850.55-0.24
Current ratio
0.110.080.081.90.62
Interest coverage
-3.112.62-3.93-263.44-75.71
Income quality
0.410.430.370.360.54
Dividend Yield
00000
Payout ratio
00000
Sales general and administrative to revenue
2.311.320.920.871.35
Research and developement to revenue
00000
Intangibles to total assets
00.530.840.560.31
Capex to operating cash flow
000.010.010.01
Capex to revenue
00000
Capex to depreciation
-0.13-0.14-0.1-0.02-0.03
Stock based compensation to revenue
0.210.130.090.080.08
Graham number
0.250.310.10.190.03
ROIC
2.751.39K-0.7-0.58-3.02
Return on tangible assets
-13.55-11.84-4.82-2.23-2.8
Graham Net
-0.04-0.05-0.040-0.02
Working capital
-2.98M-4.91M-4.48M1.73M-1.33M
Tangible asset value
-2.93M-4.18M-5.4M1.18M-1.12M
Net current asset value
-2.99M-4.99M-6.27M159.83K-2.12M
Invested capital
-0.59-0.92.140.144.08
Average receivables
114.12K99.07K85.2K86.72K214.15K
Average payables
323.92K615.4K1.36M1.1M584.94K
Average inventory
48.01K83.24K82.83K115.07K163.88K
Days sales outstanding
18.567.565.193.4221.31
Days payables outstanding
60.8272.02593.2337.01680.63
Days of inventory on hand
14.816.0729.8516.31151.97
Receivables turnover
19.6648.2770.37106.617.13
Payables turnover
65.070.629.860.54
Inventory turnover
24.6560.1612.2322.382.4
ROE
1.975.04-4.56-1.45-28.04
Capex per share
00000

Quarterly Fundamentals Overview

Last date of statement is 2023-09-30 for Q3

Metric History 2022-09-302022-12-312023-03-312023-06-30 2023-09-30
2.02K2.02K2.02K2.02K2.02K
Revenue per share
0.0100.010.010.01
Net income per share
-0.01-0.020.0100
Operating cash flow per share
-0.010000
Free cash flow per share
-0.010000
Cash per share
00000
Book value per share
0.0200.010.010.01
Tangible book value per share
-0.010000
Share holders equity per share
0.0200.010.010.01
Interest debt per share
0.010.010.010.010.01
Market cap
17.81M16.67M20.57M18.07M12.85M
Enterprise value
19.14M17.9M22.31M19.01M14.91M
P/E ratio
-2.49-0.983.54-4.5-18.37
Price to sales ratio
12.314.4411.7210.619.64
POCF ratio
-14.31-27.77-18.71-29.93-10.29
PFCF ratio
-14.31-26.72-18.71-29.93-10.27
P/B Ratio
4.4153.039.4911.498.23
PTB ratio
4.4153.039.4911.498.23
EV to sales
13.2215.4912.7111.1611.19
Enterprise value over EBITDA
-11.39-27.73-23.04-27.35-21.77
EV to operating cash flow
-15.38-29.81-20.29-31.48-11.93
EV to free cash flow
-15.38-28.68-20.29-31.48-11.92
Earnings yield
-0.1-0.260.07-0.06-0.01
Free cash flow yield
-0.07-0.04-0.05-0.03-0.1
Debt to equity
0.374.080.831.181.35
Debt to assets
0.20.280.290.340.37
Net debt to EBITDA
-0.79-1.89-1.8-1.35-3
Current ratio
0.20.620.680.540.66
Interest coverage
-66.79-20.33-14.14-4.76-7.91
Income quality
0.70.17-0.730.617.74
Dividend Yield
00000
Payout ratio
00000
Sales general and administrative to revenue
1.311.641.181.021.16
Research and developement to revenue
00000
Intangibles to total assets
0.780.310.220.240.17
Capex to operating cash flow
00.04000
Capex to revenue
0-0.02000
Capex to depreciation
0-0.1100-0.02
Stock based compensation to revenue
0.040.10.050.050.04
Graham number
0.050.020.030.020.01
ROIC
-0.29-0.480.29-0.25-0.31
Return on tangible assets
-1.07-1.360.3-0.24-0.04
Graham Net
-0.01-0.02-0.01-0.01-0.01
Working capital
-1.99M-1.33M-1.07M-1.53M-1.16M
Tangible asset value
-1.78M-1.12M793.72K253.94K620.01K
Net current asset value
-2.94M-2.12M-1.74M-2.16M-1.93M
Invested capital
0.374.080.831.181.35
Average receivables
76.97K202.94K1.12M1.26M1.28M
Average payables
586.16K756.42K879.55K877.87K746.47K
Average inventory
185.74K190.69K192.88K174.69K149.36K
Days sales outstanding
3.9726.6596.9932.87130.36
Days payables outstanding
137.3775.092.51K2.25K1.39K
Days of inventory on hand
39.916.76541.6409.37313.64
Receivables turnover
22.673.380.932.740.69
Payables turnover
0.661.20.040.040.06
Inventory turnover
2.265.370.170.220.29
ROE
-0.44-13.590.67-0.64-0.11
Capex per share
00000

HLYK Frequently Asked Questions

What is HealthLynked Corp. stock symbol ?

HealthLynked Corp. is a US stock , located in Naples of Fl and trading under the symbol HLYK

What is HealthLynked Corp. stock quote today ?

HealthLynked Corp. stock price is $0.0569 today.

Is HealthLynked Corp. stock public?

Yes, HealthLynked Corp. is a publicly traded company.

Something similar

Top by Market Cap
Same Price Range
Similar Market Cap